Met Life Investment Management, LLC Vir Biotechnology, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 50,735 shares of VIR stock, worth $375,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,735
Previous 50,735 -0.0%
Holding current value
$375,439
Previous $451,000 15.74%
% of portfolio
0.0%
Previous 0.0%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$7.63 - $12.66 $50,190 - $83,277
6,578 Added 14.9%
50,735 $451,000
Q1 2024

May 14, 2024
BUY
$8.6 - $11.9 $379,750 - $525,468
44,157 New
44,157 $447,000
Q3 2023

May 09, 2024
BUY
$9.14 - $24.62 $58,496 - $157,568
6,400 Added 16.95%
44,157 $413,000
Q2 2023

Apr 29, 2024
BUY
$23.2 - $27.29 $1.02 Million - $1.21 Million
44,157 New
44,157 $1.08 Million
Q2 2023

Aug 10, 2023
BUY
$23.2 - $27.29 $1.02 Million - $1.21 Million
44,157 New
44,157 $1.08 Million
Q1 2023

May 09, 2024
BUY
$22.26 - $30.85 $840,470 - $1.16 Million
37,757 New
37,757 $879 Million
Q4 2022

Jun 14, 2023
BUY
$19.96 - $28.22 $753,629 - $1.07 Million
37,757 New
37,757 $955,000
Q3 2022

Jun 14, 2023
BUY
$18.26 - $31.1 $689,442 - $1.17 Million
37,757 New
37,757 $727,000
Q2 2022

May 10, 2024
BUY
$19.08 - $26.7 $87,405 - $122,312
4,581 Added 13.81%
37,757 $961,000
Q2 2022

Jun 20, 2023
BUY
$19.08 - $26.7 $720,403 - $1.01 Million
37,757 New
37,757 $961,000
Q2 2022

Mar 22, 2023
BUY
$19.08 - $26.7 $87,405 - $122,312
4,581 Added 13.81%
37,757 $961,000
Q2 2022

Aug 11, 2022
BUY
$19.08 - $26.7 $87,405 - $122,312
4,581 Added 13.81%
37,757 $962,000
Q1 2022

May 10, 2024
BUY
$21.19 - $40.01 $702,999 - $1.33 Million
33,176 New
33,176 $853,000
Q1 2022

Jun 20, 2023
BUY
$21.19 - $40.01 $702,999 - $1.33 Million
33,176 New
33,176 $853,000
Q1 2022

Mar 22, 2023
BUY
$21.19 - $40.01 $244,405 - $461,475
11,534 Added 53.29%
33,176 $853,000
Q1 2022

May 12, 2022
BUY
$21.19 - $40.01 $244,405 - $461,475
11,534 Added 53.29%
33,176 $853,000
Q4 2021

Jun 21, 2023
BUY
$30.97 - $54.03 $670,252 - $1.17 Million
21,642 New
21,642 $906,000
Q3 2021

Jun 21, 2023
BUY
$34.9 - $54.54 $755,305 - $1.18 Million
21,642 New
21,642 $941,000
Q2 2021

May 17, 2024
BUY
$38.75 - $51.0 $49,212 - $64,770
1,270 Added 6.23%
21,642 $1.02 Million
Q2 2021

Mar 22, 2023
BUY
$38.75 - $51.0 $49,212 - $64,770
1,270 Added 6.23%
21,642 $1.02 Million
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $49,212 - $64,770
1,270 Added 6.23%
21,642 $1.02 Million
Q1 2021

May 17, 2024
SELL
$26.34 - $83.07 $626,496 - $1.98 Million
-23,785 Reduced 53.86%
20,372 $1.04 Million
Q1 2021

Jun 26, 2023
BUY
$26.34 - $83.07 $536,598 - $1.69 Million
20,372 New
20,372 $1.04 Billion
Q1 2021

Mar 22, 2023
SELL
$26.34 - $83.07 $65,428 - $206,345
-2,484 Reduced 10.87%
20,372 $1.04 Million
Q1 2021

May 14, 2021
SELL
$26.34 - $83.07 $65,428 - $206,345
-2,484 Reduced 10.87%
20,372 $1.04 Million
Q4 2020

Jun 22, 2023
BUY
$25.51 - $43.38 $583,056 - $991,493
22,856 New
22,856 $612,000
Q3 2020

May 24, 2024
BUY
$28.28 - $53.6 $64,280 - $121,832
2,273 Added 11.04%
22,856 $785 Million
Q3 2020

Jun 26, 2023
BUY
$28.28 - $53.6 $646,367 - $1.23 Million
22,856 New
22,856 $784,000
Q3 2020

Mar 22, 2023
BUY
$28.28 - $53.6 $64,280 - $121,832
2,273 Added 11.04%
22,856 $784,000
Q3 2020

Nov 13, 2020
BUY
$28.28 - $53.6 $64,280 - $121,832
2,273 Added 11.04%
22,856 $785,000
Q2 2020

May 24, 2024
SELL
$27.89 - $47.86 $657,478 - $1.13 Million
-23,574 Reduced 53.39%
20,583 $843 Million
Q2 2020

Jun 26, 2023
BUY
$27.89 - $47.86 $574,059 - $985,102
20,583 New
20,583 $843,000
Q2 2020

Mar 22, 2023
BUY
$27.89 - $47.86 $479,735 - $823,239
17,201 Added 508.6%
20,583 $843,000
Q2 2020

Aug 14, 2020
BUY
$27.89 - $47.86 $479,735 - $823,239
17,201 Added 508.6%
20,583 $843,000
Q1 2020

Jul 12, 2023
BUY
$12.04 - $60.2 $40,719 - $203,596
3,382 New
3,382 $115,000
Q1 2020

Mar 22, 2023
SELL
$12.04 - $60.2 $413,874 - $2.07 Million
-34,375 Reduced 91.04%
3,382 $115,000
Q1 2020

May 15, 2020
BUY
$12.04 - $60.2 $40,719 - $203,596
3,382 New
3,382 $116,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email